Patents Assigned to Ophthotech Corporation
  • COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
    Publication number: 20140242082
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Application
    Filed: February 21, 2014
    Publication date: August 28, 2014
    Applicant: Ophthotech Corporation
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • Methods for Treating or Preventing Ophthalmological Diseases
    Publication number: 20140179621
    Abstract: This invention relates to methods and compositions useful for the treatment or prevention of an ophthalmological disease, comprising administration of an effective amount of a PDGF antagonist and a VEGF antagonist to a mammal in need thereof.
    Type: Application
    Filed: August 9, 2013
    Publication date: June 26, 2014
    Applicant: Ophthotech Corporation
    Inventors: Samir Patel, Harvey Masonson
  • Combination therapy for the treatment of ocular neovascular disorders
    Patent number: 8685397
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Grant
    Filed: December 17, 2009
    Date of Patent: April 1, 2014
    Assignee: Ophthotech Corporation
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • Combination therapy for the treatment of ocular neovascular disorders
    Patent number: 8206707
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Grant
    Filed: May 13, 2009
    Date of Patent: June 26, 2012
    Assignee: Ophthotech Corporation
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • Combination therapy for the treatment of ocular neovascular disorders
    Patent number: 8187597
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: May 29, 2012
    Assignee: Ophthotech Corporation
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL DISEASES
    Publication number: 20120100136
    Abstract: This invention relates to methods and compositions useful for the treatment or prevention of an ophthalmological disease, comprising administration of an effective amount of a PDGF antagonist and a VEGF antagonist to a mammal in need thereof.
    Type: Application
    Filed: October 28, 2011
    Publication date: April 26, 2012
    Applicant: OPHTHOTECH CORPORATION
    Inventors: Samir PATEL, Harvey Masonson
  • Combination therapy for the treatment of ocular neovascular disorders
    Patent number: 7759472
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Grant
    Filed: August 26, 2004
    Date of Patent: July 20, 2010
    Assignee: Ophthotech Corporation
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
    Publication number: 20100129364
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Application
    Filed: December 17, 2009
    Publication date: May 27, 2010
    Applicant: Ophthotech Corporation
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
    Publication number: 20100119522
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Application
    Filed: September 22, 2009
    Publication date: May 13, 2010
    Applicant: Ophthotech Corporation
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
    Publication number: 20100111942
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Application
    Filed: May 13, 2009
    Publication date: May 6, 2010
    Applicant: OPHTHOTECH CORPORATION
    Inventors: DAVID SHIMA, PERRY CALIAS, ANTHONY P. ADAMIS